MOH and HSA tighten measures against etomidate vapes

MOH and HSA tighten measures against etomidate vapes


SINGAPORE – Etomidate vape reoffenders now face “significantly shortened” processing times to be placed on supervision or admitted to the drug rehabilitation centre (DRC), under tougher measures rolled out by Singapore’s health authorities since Oct 1.

Of the 1,544 etomidate vaporiser offenders caught from Sept 1, 2025, to Sept 30, 2026, 367 – or one in five – reoffended, with some caught three or more times, the Ministry of Health (MOH) and Health Sciences Authority (HSA) said in a joint statement on Nov 19.

In the same period, 67 etomidate reoffenders aged 16 and above were admitted to the DRC, the two authorities said.

Twenty-seven of them have since been released and are monitored on supervision orders, which require them to report regularly for urine or hair tests.

“Vaping offences involving etomidate continue to be a concern, despite stepped up enforcement and enhanced penalties since Sept 1, 2025,” the authorities said. “In view of these trends, the Ministry of Health and the Health Sciences Authority have put in place faster and tougher actions since Oct 1, 2026.”

The measures include more surprise urine and hair tests for offenders undergoing rehabilitation to detect the use of etomidate or other psychoactive substances, as well as to catch repeat offenders early.

Those aged 16 and above, who do not cooperate or who reoffend during rehabilitation, may be subjected to escalated actions such as tighter supervision or admission to the DRC.

Alongside faster processing into supervision or DRCs, MOH and HSA said that offenders admitted to the DRC a second time will face a longer mandatory stay – double the previous duration.

In a Facebook post on Nov 19, Minister for Health Ong Ye Kung said it is worrying that many of the etomidate vape reoffenders are young people, adding that enforcement methods will be further improved.




Read Full Article At Source

Share. Save. Don't Miss The Buzz: FacebookRedditTelegramWhatsApp

Leave a Reply

Your email address will not be published. Required fields are marked *